## Founding Date | 2001 |

Momenta Pharmaceuticals is a subsidiary of Johnson & Johnson

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 283.1m | 63.9m | 35.5m | 52.3m | 89.7m | 109.6m | 138.9m | 75.6m | 23.9m |

## R&D expense | 64.7m | 80.3m | 104.0m | 106.5m | 126.0m | 119.9m | 149.2m | 124.0m | 144.5m |

## General and administrative expense | 38.7m | 43.7m | 41.1m | 45.2m | 48.1m | 64.5m | 82.2m | 149.8m | |

## Operating expense total | 103.4m | 124.0m | 145.1m | 151.6m | 174.1m | 184.3m | 231.4m | 209.1m | 335.6m |

## EBIT | 179.7m | (60.1m) | (109.6m) | (99.4m) | (84.4m) | (74.7m) | (92.6m) | (181.3m) | (298.1m) |

| 63% | (94%) | (309%) | (190%) | (94%) | (68%) | (67%) | (240%) | (1249%) |

## Interest expense | 91.0k | 1.5m | 1.2m | 796.0k | 1.1m | 53.7m | 4.5m | 5.3m | 8.0m |

## Interest income | 746.0k | 1.2m | 950.0k | 548.0k | 808.0k | 2.2m | 4.4m | 6.2m | 9.2m |

## Income tax expense | |||||||||

## Net Income | 180.4m | (58.6m) | (108.4m) | (98.6m) | (83.3m) | (21.0m) | (88.1m) | (176.1m) | (290.1m) |

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | 180.4m | (58.6m) | (108.4m) | (98.6m) | (83.3m) | (21.0m) | (88.1m) | (176.1m) | (290.1m) |

## Depreciation and Amortization | 4.1m | 6.4m | 8.2m | 8.7m | 8.7m | 1.5m | 8.0m | 11.1m | 12.8m |

## Accounts Receivable | 26.3m | 17.4m | (2.3m) | 5.7m | (12.0m) | (49.1m) | 55.2m | 3.7m | 3.4m |

## Accounts Payable | 315.0k | (1.1m) | 2.7m | 1.1m | (3.4m) | (1.0m) | 7.4m | (1.2m) | 4.8m |

## Cash From Operating Activities | 213.7m | 9.0m | (86.8m) | (65.2m) | (71.5m) | 7.9m | (30.4m) | (155.6m) | (204.8m) |

## Purchases of PP&E | (8.7m) | (15.5m) | (9.4m) | (8.4m) | (4.1m) | (5.6m) | (17.1m) | (9.0m) | (1.8m) |

## Cash From Investing Activities | (268.7m) | (7.4m) | 58.6m | 75.2m | (163.8m) | 80.0m | (121.1m) | 98.1m | 42.0m |

## Long-term Borrowings | (1.7m) | ||||||||

## Cash From Financing Activities | 3.6m | 2.2m | 5.0m | 21.6m | 235.5m | 1.3m | 74.3m | 247.1m | 261.0m |

## Net Change in Cash | (51.4m) | 3.7m | (23.2m) | 31.6m | 112.0k | 89.3m | (77.1m) | 189.5m | 98.1m |

## Interest Paid | 91.0k |

USD | Q2, 2011 |
---|---|

## Financial Leverage | 1 x |